The ventilators—the Philips Respironics, Inc. Trilogy EVO, Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal—have been assigned a Class I recall, which is the most serious type of ...

Specifically, certain reworked Philips Respironics Trilogy 100/200 Ventilators, as the FDA has asked for additional safety testing on the silicone foam material used to replace the PE-PUR foam.

The use of in-line nebulizers placed in certain locations may lead to aerosol deposits forming over time on the ventilator flow sensor. Should this occur, there is a possibility of inaccurate flow ...

Federal regulators are heightening their warning about devices made by Philips Respironics used to treat ... In December, the company also recalled its Trilogy 100 and 200 style ventilators.

The FDA cited Philips Healthcare ($PHG) subsidiary Philips Respironics with a Class 1 recall--the agency's most serious designation--for 600 of the company's Trilogy ...

Philips Respironics, a subsidiary of Koninklijke Philips, notified customers to update to the latest software version of its Trilogy Evo continuous ventilator devices due to a possible power ...

Also Read: Philips Backs Annual Guidance On Higher Q2 Earnings Despite China Weakness In March, Philips Respironics notified customers to update the latest software related to Trilogy Evo ...

Philips Healthcare's Respironics is recalling some of its V60 ventilators over a motor malfunction--courtesy of Philips Healthcare Philips Healthcare's ($PHG ...

HHS first contracted Respironics to make the ventilators to be stockpiled for emergency use in 2015. The ventilators, called the Trilogy Evo Universal, were FDA approved last summer. In September ...